Steve Salloway

1.9k total citations · 1 hit paper
16 papers, 851 citations indexed

About

Steve Salloway is a scholar working on Psychiatry and Mental health, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Steve Salloway has authored 16 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 3 papers in Neurology and 3 papers in Cognitive Neuroscience. Recurrent topics in Steve Salloway's work include Dementia and Cognitive Impairment Research (7 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Functional Brain Connectivity Studies (2 papers). Steve Salloway is often cited by papers focused on Dementia and Cognitive Impairment Research (7 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Functional Brain Connectivity Studies (2 papers). Steve Salloway collaborates with scholars based in United States. Steve Salloway's co-authors include Jeffrey L. Cummings, Paul Malloy, Michael S. Mega, Carol J. Farran, Carolyn S. Wilken, Jeffrey L. Cummings, Jeong E. Nam Shin, L A Kurjanczyk, Leonard A. Mermel and G. O. Aspinall and has published in prestigious journals such as Infection and Immunity, The Gerontologist and Alzheimer s & Dementia.

In The Last Decade

Steve Salloway

16 papers receiving 795 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Donanemab: Appropriate use recommendations

2025 39 citations D. J. Selkoe, Suzanne E. Schindler et al. The Journal of Prevention of Alzheimer s Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steve Salloway United States	10	335	187	138	127	119	16	851
Omar M. Alhassoon United States	19	224 0.7×	333 1.8×	299 2.2×	147 1.2×	64 0.5×	29	1.5k
G. E. Berrios United Kingdom	20	416 1.2×	188 1.0×	334 2.4×	84 0.7×	34 0.3×	61	1.1k
John R. Absher United States	16	382 1.1×	200 1.1×	61 0.4×	115 0.9×	22 0.2×	43	882
D. Gourion France	13	222 0.7×	109 0.6×	385 2.8×	113 0.9×	37 0.3×	30	904
Hale Yapıcı Eser Türkiye	13	191 0.6×	104 0.6×	325 2.4×	124 1.0×	32 0.3×	45	883
Massimiliano Aragona Italy	16	188 0.6×	111 0.6×	366 2.7×	41 0.3×	106 0.9×	55	818
Sarah H. Turbott New Zealand	14	486 1.5×	153 0.8×	217 1.6×	21 0.2×	75 0.6×	19	828
Joseph L. Zentner Germany	11	195 0.6×	171 0.9×	143 1.0×	39 0.3×	90 0.8×	20	832
Stefan Gutwinski Germany	18	138 0.4×	226 1.2×	321 2.3×	58 0.5×	58 0.5×	75	1.1k
Ho-Kyoung Yoon South Korea	18	132 0.4×	141 0.8×	246 1.8×	32 0.3×	77 0.6×	40	990

Countries citing papers authored by Steve Salloway

Since Specialization

Citations

This map shows the geographic impact of Steve Salloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Salloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Salloway more than expected).

Fields of papers citing papers by Steve Salloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Salloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Salloway. The network helps show where Steve Salloway may publish in the future.

Co-authorship network of co-authors of Steve Salloway

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Salloway. A scholar is included among the top collaborators of Steve Salloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Salloway. Steve Salloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Selkoe, D. J., Suzanne E. Schindler, Paul Aisen, et al.. (2025). Donanemab: Appropriate use recommendations. The Journal of Prevention of Alzheimer s Disease. 12(5). 100150–100150. 39 indexed citations breakdown →

Lee, Athene, et al.. (2023). The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry. The Journal of Prevention of Alzheimer s Disease. 10(2). 152–161. 5 indexed citations

Cummings, Jeffrey L. & Steve Salloway. (2021). Aducanumab: Appropriate use recommendations. Alzheimer s & Dementia. 18(3). 531–533. 38 indexed citations

Alber, Jessica, et al.. (2019). Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer's Disease Prevention.. PubMed. 4(4). 213–214. 9 indexed citations

Vellas, Bruno, Randall J. Bateman, Kaj Blennow, et al.. (2015). ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE. The Journal of Prevention of Alzheimer s Disease. 2(2). 1–8. 32 indexed citations

Belanger, Heather G., et al.. (2004). Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale. Archives of Clinical Neuropsychology. 20(2). 183–189. 18 indexed citations

Salloway, Steve. (2002). The Relationship of MRI Subcortical Hyperintensities to Treatment Response in a Trial of Sertraline in Geriatric Depressed Outpatients. American Journal of Geriatric Psychiatry. 10(1). 107–111. 10 indexed citations

Salloway, Steve & Jessica F White. (1997). Paroxysmal limbic disorders in neuropsychiatry. Journal of Neuropsychiatry. 9(3). 403–419. 8 indexed citations

Mega, Michael S., Jeffrey L. Cummings, Steve Salloway, & Paul Malloy. (1997). The limbic system: an anatomic, phylogenetic, and clinical perspective. Journal of Neuropsychiatry. 9(3). 315–330. 219 indexed citations

10.

Malloy, Paul, Jeffrey L. Cummings, C. Edward Coffey, et al.. (1997). Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry. 9(2). 189–197. 116 indexed citations

11.

Salloway, Steve. (1996). Clinical-pathological case conference: depression, behavior change, and subcortical dementia in a 57-year-old woman.[clinical conference]. Journal of Neuropsychiatry. 8(2). 215–221. 3 indexed citations

12.

Salloway, Steve, et al.. (1996). Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infection and Immunity. 64(8). 2945–2949. 104 indexed citations

13.

Duffy, James, et al.. (1994). Treatment strategies for patients with dysexecutive syndromes. Journal of Neuropsychiatry. 6(4). 411–418. 22 indexed citations

14.

Salloway, Steve, et al.. (1993). Case conference: behavior change, hallucinations, and memory loss in a 25-year-old man [clinical conference]. Journal of Neuropsychiatry. 5(4). 435–441. 2 indexed citations

15.

Fogel, Barry S., James Duffy, M E McNamara, & Steve Salloway. (1992). Skeptics and enthusiasts in neuropsychiatry. Journal of Neuropsychiatry. 4(4). 458–462. 6 indexed citations

16.

Farran, Carol J., et al.. (1991). Finding Meaning: An Alternative Paradigm for Alzheimer's Disease Family Caregivers. The Gerontologist. 31(4). 483–489. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact